Generation and application of novel hES cell reporter lines for the differentiation and maturation of hPS cell-derived islet-like clusters
The significant advances in the differentiation of human pluripotent stem (hPS) cells into pancreatic endocrine cells,including functional ?-cells,have been based on a detailed understanding of the underlying developmental mechanisms. However,the final differentiation steps,leading from endocrine progenitors to mono-hormonal and mature pancreatic endocrine cells,remain to be fully understood and this is reflected in the remaining shortcomings of the hPS cell-derived islet cells (SC-islet cells),which include a lack of ?-cell maturation and variability among different cell lines. Additional signals and modifications of the final differentiation steps will have to be assessed in a combinatorial manner to address the remaining issues and appropriate reporter lines would be useful in this undertaking. Here we report the generation and functional validation of hPS cell reporter lines that can monitor the generation of INS+ and GCG+ cells and their resolution into mono-hormonal cells (INSeGFP,INSeGFP/GCGmCHERRY) as well as ?-cell maturation (INSeGFP/MAFAmCHERRY) and function (INSGCaMP6). The reporter hPS cell lines maintained strong and widespread expression of pluripotency markers and differentiated efficiently into definitive endoderm and pancreatic progenitor (PP) cells. PP cells from all lines differentiated efficiently into islet cell clusters that robustly expressed the corresponding reporters and contained glucose-responsive,insulin-producing cells. To demonstrate the applicability of these hPS cell reporter lines in a high-content live imaging approach for the identification of optimal differentiation conditions,we adapted our differentiation procedure to generate SC-islet clusters in microwells. This allowed the live confocal imaging of multiple SC-islets for a single condition and,using this approach,we found that the use of the N21 supplement in the last stage of the differentiation increased the number of monohormonal ?-cells without affecting the number of ?-cells in the SC-islets. The hPS cell reporter lines and the high-content live imaging approach described here will enable the efficient assessment of multiple conditions for the optimal differentiation and maturation of SC-islets.
View Publication
产品号#:
05120
100-0483
100-0484
34811
34815
34821
34825
34850
34860
85850
85857
产品名:
STEMdiff™胰腺祖细胞试剂盒
Hausser Scientificᵀᴹ 明线血球计数板
ReLeSR™
AggreWell™ 800 24孔板,1个
AggreWell™ 800 24孔板,5个
AggreWell™ 800 6孔板,1个
AggreWell™ 800 6孔板,5个
AggreWell™ 800 24孔板启动套装
AggreWell™ 800 6孔板启动套装
mTeSR™1
mTeSR™1
(Sep 2024)
Cell Reports Methods 4 9
A compact, versatile drug-induced splicing switch system with minimal background expression
SummaryGene-switch techniques hold promising applications in contemporary genetics research,particularly in disease treatment and genetic engineering. Here,we developed a compact drug-induced splicing system that maintains low background using a human ubiquitin C (hUBC) promoter and optimized drug (LMI070) binding sequences based on the Xon switch system. To ensure precise subcellular localization of the protein of interest (POI),we inserted a 2A self-cleaving peptide between the extra N-terminal peptide and POI. This streamlined and optimized switch system,named miniXon2G,effectively regulated POIs in different subcellular localizations both in vitro and in vivo. Furthermore,miniXon2G could be integrated into endogenous gene loci,resulting in precise,reversible regulation of target genes by both endogenous regulators and drugs. Overall,these findings highlight the performance of miniXon2G in controlling protein expression with great potential for general applicability to diverse biological scenarios requiring precise and delicate regulation. Graphical abstract Highlights•miniXon2G is a compact and versatile version of the Xon gene-switch system•A P2A peptide eliminates residual peptides from functional proteins•We demonstrate applications on multiple proteins of interest•miniXon2G is a precise and reversible switch system with minimal background expression MotivationThe Xon drug-inducible splice-switch system is a simple and highly adaptable tool for regulated protein expression. We sought to further engineer this system to expand its applications in contemporary genetics research. In particular,we focused on reducing the size of the switch elements,maintaining minimal background expression,introducing a feature to remove extraneous peptide fragments,and demonstrating genomic integration and validation on a range of targets. Chi et al. develop a compact and versatile miniXon2G drug-inducible splice-switch system based on the Xon system. It features a reduced size,minimal background,and the removal of extraneous peptide fragments,enabling application to various biological scenarios that require precise expression control.
View Publication
产品号#:
85850
85857
产品名:
mTeSR™1
mTeSR™1
(Jun 2025)
Development (Cambridge,England) 152 12
Ciliary biology intersects autism and congenital heart disease
Autism spectrum disorder (ASD) and congenital heart disease (CHD) frequently co-occur,yet the underlying molecular mechanisms of this comorbidity remain unknown. Given that children with CHD are identified as newborns,understanding which CHD variants are associated with autism could help select individuals for early intervention. Autism gene perturbations commonly dysregulate neural progenitor cell (NPC) biology,so we hypothesized that CHD genes disrupting neurogenesis are more likely to increase ASD risk. Therefore,we performed an in vitro pooled CRISPR interference screen to identify CHD genes disrupting NPC biology and identified 45 CHD genes. A cluster of ASD and CHD genes are enriched for ciliary biology,and perturbing any one of seven such genes (CEP290,CHD4,KMT2E,NSD1,OFD1,RFX3 and TAOK1) impairs primary cilia formation in vitro. In vivo investigation of TAOK1 in Xenopus tropicalis reveals a role in motile cilia formation and heart development,supporting its prediction as a CHD gene. Together,our findings highlight a set of CHD genes that may carry risk for ASD and underscore the role of cilia in shared ASD and CHD biology.
View Publication
产品号#:
100-0276
100-1130
产品名:
mTeSR™ Plus
mTeSR™ Plus
(Oct 2024)
bioRxiv 16
miR126-mediated impaired vascular integrity in Rett syndrome
Rett syndrome (RTT) is a neurodevelopmental disorder that is caused by mutations in melty-CpG binding protein 2 (MeCP2). MeCP2 is a non-cell type-specific DNA binding protein,and its mutation influences not only neural cells but also non-neural cells in the brain,including vasculature associated with endothelial cells. Vascular integrity is crucial for maintaining brain homeostasis,and its alteration may be linked to the pathology of neurodegenerative disease,but a non-neurogenic effect,especially the relationship between vascular alternation and Rett syndrome pathogenesis,has not been shown. Here,we recapitulate a microvascular network using Rett syndrome patient-derived induced pluripotent stem (iPS) cells that carry MeCP2[R306C] mutation to investigate early developmental vascular impact. To expedite endothelial cell differentiation,doxycycline (DOX)-inducible ETV2 expression vectors were inserted into the AAVS1 locus of Rett syndrome patient-derived iPS cells and its isogenic control by CRISPR/Cas9. With these endothelial cells,we established a disease microvascular network (Rett-dMVNs) and observed higher permeability in the Rett-dMVNs compared to isogenic controls,indicating altered barrier function by MeCP2 mutation. Furthermore,we unveiled that hyperpermeability is involved in the upregulation of miR126–3p in Rett syndrome patient-derived endothelial cells by microRNA profiling and RNAseq,and rescue of miR126–3p level can recover their phenotype. We discover miR126–3p-mediated vascular impairment in Rett syndrome patients and suggest the potential application of these findings for translational medicine.
View Publication
产品号#:
100-0276
100-1130
产品名:
mTeSR™ Plus
mTeSR™ Plus
(May 2024)
Cardiovascular Research 120 9
Inhibition of TBL1 cleavage alleviates doxorubicin-induced cardiomyocytes death by regulating the Wnt/?-catenin signal pathway
AbstractAimsDoxorubicin (DOX) is a widely used anthracycline anticancer agent; however,its irreversible effects on the heart can result in DOX-induced cardiotoxicity (DICT) after cancer treatment. Unfortunately,the pathophysiology of DICT has not yet been fully elucidated,and there are no effective strategies for its prevention or treatment. In this investigation,the novel role of transducin beta-like protein 1 (TBL1) in developing and regulating DICT was explored.Methods and resultsWe observed a reduction in TBL1 protein expression levels as well as cleavage events in the transplanted cardiac tissues of patients diagnosed with Dilated Cardiomyopathy and DICT. It was revealed that DOX selectively induces TBL1 cleavage at caspase-3 preferred sites—D125,D136,and D215. Interestingly,overexpression of the uncleaved TBL1 mutant (TBL1uclv) variant reduced apoptosis,effectively preventing DOX-induced cell death. We confirmed that cleaved TBL1 cannot form a complex with ?-catenin. As a result,Wnt reporter activity and Wnt target gene expression collectively indicate a decrease in Wnt/?-catenin signalling,leading to DICT progression. Furthermore,the cleaved TBL1 triggered DOX-induced abnormal electrophysiological features and disrupted calcium homeostasis. However,these effects were improved in TBL1uclv-overexpressing human-induced pluripotent stem cell-derived cardiomyocytes. Finally,in a DICT mouse model,TBL1uclv overexpression inhibited the DICT-induced reduction of cardiac contractility and collagen accumulation,ultimately protecting cardiomyocytes from cell death.ConclusionOur findings reveal that the inhibition of TBL1 cleavage not only mitigates apoptosis but also enhances cardiomyocyte function,even in the context of DOX administration. Consequently,this study's results suggest that inhibiting TBL1 cleavage may be a novel strategy to ameliorate DICT. Graphical Abstract Graphical Abstract
View Publication
产品号#:
100-0483
100-0484
05990
产品名:
Hausser Scientificᵀᴹ 明线血球计数板
ReLeSR™
TeSR™-E8™
(Apr 2025)
Cancer Chemotherapy and Pharmacology 95 1
Neurofilament light chain as a marker for neuronal damage: integrating in vitro studies and clinical findings in patients with oxaliplatin-induced neuropathy
PurposeOxaliplatin-induced peripheral neuropathy (OIPN) is a chronic,debilitating late effect following oxaliplatin treatment. Neurofilament light chain (NfL) is a structural protein found in nerve axons that was investigated upon oxaliplatin exposure in vitro and in vivo correlated to symptoms of OIPN in colorectal cancer patients receiving oxaliplatin.MethodsHuman sensory neurons,derived from induced pluripotent stem cells,were exposed to clinically relevant concentrations of oxaliplatin in vitro,with NfL concentrations measured in the cell medium. The prospective clinical study included patients with colorectal cancer undergoing chemotherapy therapy with or without oxaliplatin. Possible OIPN was defined as bilateral presence of numbness and/or presence of pricking sensations in the feet documented in an interview at the time of blood sampling prior to,3,and 6 months after initiating treatment.ResultsOxaliplatin exposure led to a dose-dependent NfL increase in vitro. In the clinical cohort of 30 patients (18 in the oxaliplatin group),NfL levels rose at 3 and 6 months compared to controls. NfL level changes correlated to OIPN symptoms at the 6-month timepoint (rho 0.81,p?0.001). However,the interindividual variation was substantial,and most patients showed only a minor increase in NfL.ConclusionBoth in vitro and clinical data indicate that oxaliplatin exposure results in elevated NfL levels. Further prospective studies are needed to evaluate NfL as an early biomarker for OIPN,specifically focusing on the timing of blood sampling during chemotherapy treatment to enable the timely reduction of oxaliplatin.Supplementary InformationThe online version contains supplementary material available at 10.1007/s00280-025-04773-w.
View Publication
产品号#:
85850
85857
产品名:
mTeSR™1
mTeSR™1
(Sep 2024)
Scientific Reports 14
Mitochondrial dysfunction and increased reactive oxygen species production in MECP2 mutant astrocytes and their impact on neurons
Studies on MECP2 function and its implications in Rett Syndrome (RTT) have traditionally centered on neurons. Here,using human embryonic stem cell (hESC) lines,we modeled MECP2 loss-of-function to explore its effects on astrocyte (AST) development and dysfunction in the brain. Ultrastructural analysis of RTT hESC-derived cerebral organoids revealed significantly smaller mitochondria compared to controls (CTRs),particularly pronounced in glia versus neurons. Employing a multiomics approach,we observed increased gene expression and accessibility of a subset of nuclear-encoded mitochondrial genes upon mutation of MECP2 in ASTs compared to neurons. Analysis of hESC-derived ASTs showed reduced mitochondrial respiration and altered key proteins in the tricarboxylic acid cycle and electron transport chain in RTT versus CTRs. Additionally,RTT ASTs exhibited increased cytosolic amino acids under basal conditions,which were depleted upon increased energy demands. Notably,mitochondria isolated from RTT ASTs exhibited increased reactive oxygen species and influenced neuronal activity when transferred to cortical neurons. These findings underscore MECP2 mutation's differential impact on mitochondrial and metabolic pathways in ASTs versus neurons,suggesting that dysfunctional AST mitochondria may contribute to RTT pathophysiology by affecting neuronal health.
View Publication
产品号#:
08570
100-0483
100-0484
100-0276
100-1130
产品名:
STEMdiff™ 脑类器官试剂盒
Hausser Scientificᵀᴹ 明线血球计数板
ReLeSR™
mTeSR™ Plus
mTeSR™ Plus
(Apr 2025)
Cell Death & Disease 16 1
CITK modulates BRCA1 recruitment at DNA double strand breaks sites through HDAC6
Citron Kinase (CITK) is a protein encoded by the CIT gene,whose pathogenic variants underlie microcephalic phenotypes that characterize MCPH17 syndrome. In neural progenitors,CITK loss leads to microtubule instability,resulting in mitotic spindle positioning defects,cytokinesis failure,and accumulation of DNA double strand breaks (DSBs),ultimately resulting in TP53-dependent senescence and apoptosis. Although DNA damage accumulation has been associated with impaired homologous recombination (HR),the role of CITK in this process and whether microtubule dynamics are involved is still unknown. In this report we show that CITK is required for proper BRCA1 localization at sites of DNA DSBs. We found that CITK’s scaffolding,rather than its catalytic activity,is necessary for maintaining BRCA1 interphase levels in progenitor cells during neurodevelopment. CITK regulates the nuclear levels of HDAC6,a modulator of both microtubule stability and DNA damage repair. Targeting HDAC6 in CITK-deficient cells increases microtubule stability and recovers BRCA1 localization defects and DNA damage levels to that detected in controls. In addition,the CIT-HDAC6 axis is functionally relevant in a MCPH17 zebrafish model,as HDAC6 targeting recovers the head size phenotype produced by interfering with the CIT orthologue gene. These data provide novel insights into the functional interplay between HR and microtubule dynamics and into the pathogenesis of CITK based MCPH17,which may be relevant for development of therapeutic strategies.
View Publication
产品号#:
85850
85857
产品名:
mTeSR™1
mTeSR™1
(Feb 2024)
Nucleic Acids Research 52 9
HBO1 determines SMAD action in pluripotency and mesendoderm specification
AbstractTGF-? signaling family plays an essential role to regulate fate decisions in pluripotency and lineage specification. How the action of TGF-? family signaling is intrinsically executed remains not fully elucidated. Here,we show that HBO1,a MYST histone acetyltransferase (HAT) is an essential cell intrinsic determinant for TGF-? signaling in human embryonic stem cells (hESCs). HBO1?/? hESCs fail to response to TGF-? signaling to maintain pluripotency and spontaneously differentiate into neuroectoderm. Moreover,HBO1 deficient hESCs show complete defect in mesendoderm specification in BMP4-triggered gastruloids or teratomas. Molecularly,HBO1 interacts with SMAD4 and co-binds the open chromatin labeled by H3K14ac and H3K4me3 in undifferentiated hESCs. Upon differentiation,HBO1/SMAD4 co-bind and maintain the mesoderm genes in BMP4-triggered mesoderm cells while lose chromatin occupancy in neural cells induced by dual-SMAD inhibition. Our data reveal an essential role of HBO1,a chromatin factor to determine the action of SMAD in both human pluripotency and mesendoderm specification. Graphical Abstract Graphical Abstract
View Publication
产品号#:
85850
85857
产品名:
mTeSR™1
mTeSR™1
(Nov 2024)
Scientific Reports 14
Comparison of iPSC-derived human intestinal epithelial cells with Caco-2 cells and human in vivo data after exposure to Lactiplantibacillus plantarum WCFS1
To investigate intestinal health and its potential disruptors in vitro,representative models are required. Human induced pluripotent stem cell (hiPSC)-derived intestinal epithelial cells (IECs) more closely resemble the in vivo intestinal tissue than conventional in vitro models like human colonic adenocarcinoma Caco-2 cells. However,the potential of IECs to study immune-related responses upon external stimuli has not been investigated in detail yet. The aim of the current study was to evaluate immune-related effects of IECs by challenging them with a pro-inflammatory cytokine cocktail. Subsequently,the effects of Lactiplantibacillus plantarum WCFS1 were investigated in unchallenged and challenged IECs. All exposures were compared to Caco-2 cells and in vivo data where possible. Upon the inflammatory challenge,IECs and Caco-2 cells induced a pro-inflammatory response which was strongest in IECs. Heat-killed L. plantarum exerted the strongest effect on immune parameters in the IEC model,while L. plantarum in the stationary growth phase had most pronounced effects on immune-related gene expression in Caco-2 cells. Unfortunately,comparison to in vivo transcriptomics data showed limited similarities,which could be explained by essential differences in the study setups. Altogether,hiPSC-derived IECs show a high potential as a model to study immune-related responses in the intestinal epithelium in vitro.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-024-74802-w.
View Publication
产品号#:
85850
85857
产品名:
mTeSR™1
mTeSR™1
(Feb 2025)
Nucleic Acids Research 53 4
NEAT1-mediated regulation of proteostasis and mRNA localization impacts autophagy dysregulation in Rett syndrome
Rett syndrome (RTT) is a severe neurodevelopmental disorder primarily caused by loss-of-function mutations in the MECP2 gene,resulting in diverse cellular dysfunctions. Here,we investigated the role of the long noncoding RNA (lncRNA) NEAT1 in the context of MeCP2 deficiency using human neural cells and RTT patient samples. Through single-cell RNA sequencing and molecular analyses,we found that NEAT1 is markedly downregulated in MECP2 knockout (KO) cells at various stages of neural differentiation. NEAT1 downregulation correlated with aberrant activation of the mTOR pathway,abnormal protein metabolism,and dysregulated autophagy,contributing to the accumulation of protein aggregates and impaired mitochondrial function. Reactivation of NEAT1 in MECP2-KO cells rescued these phenotypes,indicating its critical role downstream of MECP2. Furthermore,direct RNA–RNA interaction was revealed as the key process for NEAT1 influence on autophagy genes,leading to altered subcellular localization of specific autophagy-related messenger RNAs and impaired biogenesis of autophagic complexes. Importantly,NEAT1 restoration rescued the morphological defects observed in MECP2-KO neurons,highlighting its crucial role in neuronal maturation. Overall,our findings elucidate lncRNA NEAT1 as a key mediator of MeCP2 function,regulating essential pathways involved in protein metabolism,autophagy,and neuronal morphology.
View Publication
产品号#:
08581
08582
85850
85857
产品名:
STEMdiff™SMADi神经诱导试剂盒
STEMdiff™SMADi神经诱导试剂盒,2套
mTeSR™1
mTeSR™1
(Mar 2024)
Research Square 309
Ultra-fast genetically encoded sensor for precise real-time monitoring of physiological and pathophysiological peroxide dynamics
Hydrogen Peroxide (H2O2) is a central oxidant in redox biology due to its pleiotropic role in physiology and pathology. However,real-time monitoring of H2O2 in living cells and tissues remains a challenge. We address this gap with the development of an optogenetic hydRogen perOxide Sensor (oROS),leveraging the bacterial peroxide binding domain OxyR. Previously engineered OxyR-based fluorescent peroxide sensors lack the necessary sensitivity and response speed for effective real-time monitoring. By structurally redesigning the fusion of Escherichia coli (E. coli) ecOxyR with a circularly permutated green fluorescent protein (cpGFP),we created a novel,green-fluorescent peroxide sensor oROS-G. oROS-G exhibits high sensitivity and fast on-and-off kinetics,ideal for monitoring intracellular H2O2 dynamics. We successfully tracked real-time transient and steady-state H2O2 levels in diverse biological systems,including human stem cell-derived neurons and cardiomyocytes,primary neurons and astrocytes,and mouse brain ex vivo and in vivo. These applications demonstrate oROS’s capabilities to monitor H2O2 as a secondary response to pharmacologically induced oxidative stress and when adapting to varying metabolic stress. We showcased the increased oxidative stress in astrocytes via A?-putriscine-MAOB axis,highlighting the sensor’s relevance in validating neurodegenerative disease models. Lastly,we demonstrated acute opioid-induced generation of H2O2 signal in vivo which highlights redox-based mechanisms of GPCR regulation. oROS is a versatile tool,offering a window into the dynamic landscape of H2O2 signaling. This advancement paves the way for a deeper understanding of redox physiology,with significant implications for understanding diseases associated with oxidative stress,such as cancer,neurodegenerative,and cardiovascular diseases.
View Publication